The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.

The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.

Date of Patent:
Sep. 01, 2020

Filed:

Jan. 30, 2019
Applicants:

Albert Einstein College of Medicine, Bronx, NY (US);

The Governing Council of the University of Toronto, Toronto, CA;

Inventors:

Evripidis Gavathiotis, Flushing, NY (US);

Jonathan R. Lai, Dobbs Ferry, NY (US);

Sachdev Sidhu, Toronto, CA;

Attorney:
Primary Examiner:
Int. Cl.
CPC ...
C07K 16/18 (2006.01); A61K 47/68 (2017.01); C07K 16/00 (2006.01); G01N 33/574 (2006.01); A61K 9/127 (2006.01);
U.S. Cl.
CPC ...
C07K 16/18 (2013.01); A61K 9/127 (2013.01); A61K 47/6843 (2017.08); G01N 33/574 (2013.01); C07K 16/005 (2013.01); C07K 2317/10 (2013.01); C07K 2317/24 (2013.01); C07K 2317/55 (2013.01); C07K 2317/565 (2013.01); C07K 2317/622 (2013.01); C07K 2317/76 (2013.01); C07K 2317/92 (2013.01); G01N 2500/04 (2013.01); G01N 2510/00 (2013.01);
Abstract

Synthetic fragment antigen-binding (Fab) antibodies are disclosed that bind to an N-terminal activation site of BCL-2-associated X-protein (BAX) and inhibit BAX activation. Also disclosed are methods of using the Fabs for measuring inactive monomeric BAX levels, screening for small molecules that bind to an N-terminal activation site of BAX, inhibiting apoptotic cell death, and predicting the ability of a cancer therapy to promote apoptotic cell death.


Find Patent Forward Citations

Loading…